10zyme
10zyme develops innovative diagnostic technologies for early cancer detection, focusing on HPV and cervical cancer.
10zyme is active in the artificial intelligence (ai), biotechnology, health diagnostics space based in Europe, Middle East, and Africa (EMEA), founded in 2022.
The company sits in the artificial intelligence (ai), biotechnology, health diagnostics segment, where it competes on its core product or service.
The business is associated with Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
The company reports a headcount in the c_00001_00010 range.
| Sector | Artificial Intelligence (AI), Biotechnology, Health Diagnostics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: 10zyme.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account